Cargando…
Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies
This cohort study demonstrates how to use cumulative event count curves to create a clinically meaningful end point by simultaneously considering recurrence, progression, and survival times from the individual patient.
Autores principales: | Wang, Xiaofei, McCaw, Zachary R., Tian, Lu, Stinchcombe, Thomas E., Vokes, Everett, Ludmir, Ethan B., Wei, Lee-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285578/ https://www.ncbi.nlm.nih.gov/pubmed/37342044 http://dx.doi.org/10.1001/jamanetworkopen.2023.19055 |
Ejemplares similares
-
Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations
por: McCaw, Zachary R, et al.
Publicado: (2022) -
Assessment of Median and Mean Survival Time in Cancer Clinical Trials
por: Das, Ananya, et al.
Publicado: (2023) -
Moving beyond conventional stratified analysis to assess the treatment effect in a comparative oncology study
por: Sun, Ryan, et al.
Publicado: (2021) -
Radiotherapy Advances in Pediatric Neuro-Oncology
por: Ludmir, Ethan B., et al.
Publicado: (2018) -
End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma
por: Hoering, Antje, et al.
Publicado: (2017)